These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 3044086)

  • 21. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.
    Mertz GJ; Jones CC; Mills J; Fife KH; Lemon SM; Stapleton JT; Hill EL; Davis LG
    JAMA; 1988 Jul; 260(2):201-6. PubMed ID: 3290517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK
    N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of recurrent genital herpes with oral acyclovir.
    Salo OP
    Scand J Infect Dis Suppl; 1985; 47():67-9. PubMed ID: 3868026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genital herpes: oral treatment with acyclovir.
    Ruhnek-Forsbeck M
    Scand J Infect Dis Suppl; 1985; 47():63-6. PubMed ID: 3912973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
    Leone PA; Trottier S; Miller JM
    Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir.
    Fife KH; Almekinder J; Ofner S
    Sex Transm Dis; 2007 May; 34(5):297-301. PubMed ID: 16960547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.
    Bras AP; Sitar DS; Aoki FY
    Can J Clin Pharmacol; 2001; 8(4):207-11. PubMed ID: 11743593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
    Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS
    N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative studies of inosine pranobex and acyclovir.
    Mindel A
    Am J Med; 1988 Aug; 85(2A):7-9. PubMed ID: 2457315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of oral acyclovir in the management of genital herpes simplex.
    Sacks SL
    CMAJ; 1987 Apr; 136(7):701-7. PubMed ID: 3548933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of eczema herpeticum with oral acyclovir.
    Niimura M; Nishikawa T
    Am J Med; 1988 Aug; 85(2A):49-52. PubMed ID: 3044093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acyclovir creme in recurrent herpes genitalis].
    Laerum E; Gabrielsen BO; Halsos A; Johnson M; Moseng D; Helland S; Slørdahl M
    Tidsskr Nor Laegeforen; 1989 Mar; 109(7-8):847-9. PubMed ID: 2650015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.
    Douglas JM; Critchlow C; Benedetti J; Mertz GJ; Connor JD; Hintz MA; Fahnlander A; Remington M; Winter C; Corey L
    N Engl J Med; 1984 Jun; 310(24):1551-6. PubMed ID: 6328298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prolonged treatment with acyclovir in recurrent genital herpes. Clinical, virological, and immunological response].
    Velasco M; Saavedra T; Sepúlveda C; Suárez M
    Rev Med Chil; 1991 Aug; 119(8):876-80. PubMed ID: 1668960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term oral acyclovir treatment prevents recurrent genital herpes.
    Blom I; Bäck O; Egelrud T; Frödin T; Hellbe L; Johannisson G; Malmros-Enander I; Molin L
    Dermatologica; 1986; 173(5):220-3. PubMed ID: 3100353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.
    Wood MJ; Johnson RW; McKendrick MW; Taylor J; Mandal BK; Crooks J
    N Engl J Med; 1994 Mar; 330(13):896-900. PubMed ID: 8114860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
    Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
    Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
    Mertz GJ; Critchlow CW; Benedetti J; Reichman RC; Dolin R; Connor J; Redfield DC; Savoia MC; Richman DD; Tyrrell DL
    JAMA; 1984 Sep; 252(9):1147-51. PubMed ID: 6088819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
    Mindel A; Faherty A; Carney O; Patou G; Freris M; Williams P
    Lancet; 1988 Apr; 1(8591):926-8. PubMed ID: 2895840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.